Summary
The majority of migraine attacks are associated with gastrointestinal symptoms which add considerably to the distress and inconvenience caused by the headache. When salicylate absorption from effervescent aspirin tablets was studied during migraine, the rate of absorption was found to be reduced relative to that found in non-migrainous volunteers and in the same patients when headache-free. There is evidence that this reduced rate of absorption is caused by gastrointestinal stasis and reduced rate of gastric emptying. Patients in whom aspirin absorption was delayed were more likely to take longer to respond and to require additional treatment. Metoclopramide, which increases gastric emptying rate, has been shown to improve the rate of absorption of aspirin during migraine and also increase the rate of recovery from the attack and avoid the need for additional treatment; effects which were not shown by thiethylperazine.
It is likely that delayed absorption during migraine affects some drugs other than aspirin, such as ergotamine, and it is therefore recommended that the most rapidly absorbable formulation should be used. If such treatment is ineffective, metoclopramide may be a useful addition and should be tried before resorting to other routes of administration.
Similar content being viewed by others
References
Adams, F.: Edited translation of ‘The extant works of Areteus the Cappadocian’ pp. 294–296 (Wertheimer, London 1856).
Carstairs, L.S.: Headache and gastric emptying time. Proceedings of the Royal Society of Medicine 51: 790–791 (1958).
Heading, R.C.; Nimmo, J.; Prescott, L.F. and Tothill, P.: The dependence of paracetamol absorption on the rate of gastric emptying. British Journal of Pharmacology 47: 415–421 (1973).
Hurst, A.F. and Stewart, M.J.: Gastric and Duodenal Ulcer p. 233 (Oxford University Press, London 1929).
Kaufman, J. and Levine, I.: Acute gastric dilatation of stomach during attack of migraine. Radiology 27: 301–302 (1936).
Kreel, L.: The-use of metoclopramide in radiology. Postgraduate Medical Journal 49 (Suppl.): 42–45 (July 1973).
Lance, J.W. and Anthony, M.: Some clinical aspects of migraine. Archives of Neurology 15: 356–361 (1966).
Martin, B.K.: The absorption and distribution of salicylates; in Binns (Ed) Absorption and Distribution of Drugs, pp. 165–172 (Livingstone, London 1964).
Meier, J. and Schreier, E.: Human plasma levels of some antimigraine drugs. Headache 16: 96–104 (1976).
Nimmo, W.S.: Drugs, diseases and altered gastric emptying. Clinical Pharmacokinetics 1: 189–203 (1976).
Nimmo, J.; Heading, R.C.; Tothill, P. and Prescott, L.F.: Pharmacological modification of gastric emptying: Effects of propantheline and metoclopramide on paracetamol absorption. British Medical Journal 1: 587–589 (1973).
Orton, D.: Ergotamine tartrate levels in migraine, ergotamine tartrate overdose and normal subjects using a radioimmunoassay; in Proceedings of the Migraine Trust International Symposium 16th and 17th September 1976 (Migraine Trust, London 1976).
Reigelman, S.: Physiological and pharmacokinetic complexities in bioavailability testing. Pharmacology 8: 118–141 (1972).
Sacks, O.W.: Migraine: Evolution of a common disorder (Faber and Faber, London 1970).
Schmidt, R. and Fanchamps, A.: Effect of caffeine on intestinal absorption of ergotamine by man. European Journal of Clinical Pharmacology 7: 213–216 (1974).
Slettnes, O. and Sjaastad, O.: Metoclopramide, during attacks of migraine; in Headache: New Vistas, pp. 201–204 (Biomedical Press, Florence 1977).
Smythe, D.H.: Alimentary absorption of drugs: Physiological considerations; in Binns (Ed) Absorption and Distributions of Drugs, pp.1–15 (Livingstone, London 1964).
Volans, G.N.: The effects of food and exercise on the absorptions of effervescent aspirin. British Journal of Clinical Pharmacology 1: 137–141 (1974a).
Volans, G.N.: Absorption of effervescent aspirin during migraine. British Medical Journal 4: 265–268 (1974b).
Volans, G.N.: The effect of metoclopramide on the absorption of effervescent aspirin in migraine. British Journal of Clinical Pharmacology 2: 57–63 (1975).
Volans, G.N.: The treatment of migraine; in Turner (Ed) Advanced Medicine. Topics in Therapeutics. Vol. 2, pp. 156–172 (Pitman Medical, London 1976).
Wainscott, G.; Kaspi, T. and Volans, G.N.: The influence of thiethylperazine on the absorption of effervescent aspirin in migraine. British Journal of Clinical Pharmacology 3: 1015–1021 (1976).
Wilkinson, M.; Wainscott, G.; Ide, J.; Volans, G.N. and Wall, M.C.: An analysis of acute attacks of headache in 1000 patients; in Background to Migraine. Abstracts of the Sixth Migraine Symposium (Migraine Trust, London 1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Volans, G.N. Migraine and Drug Absorption. Clin Pharmacokinet 3, 313–318 (1978). https://doi.org/10.2165/00003088-197803040-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-197803040-00004